Atlas Trials

Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy People

Clinical trial NCT04524832 · COMPLETED

Trial details

NCT number
NCT04524832
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2020-09-29
Primary completion
2022-02-25
Enrollment
290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.